Global Peptone Market Distribution and Dynamics: Market Size is $348.16 Million in 2024

Global Peptone Market Overview

According to Global Market Monitor, the global peptone market size will reach $348.16 million in 2024 with a CAGR of 1.65% from 2024 to 2029.

Peptones are hydrolyzed proteins mainly derived from casein, plants, and meat. The main application of peptone is found in culture media formulation. Apart from this, peptones are also used in the production of fermentation, tissue culture media, and vaccine stabilizers. Peptone is used as a nutrient in culture media necessary to grow cells and microorganisms for accurate study results.

Market News

Nu-Tek BioSciences is an innovative manufacturer of critical raw materials used in cell culture media for the development and manufacturing of pharmaceuticals. In June 2024, Nu-Tek executed an agreement with IMCD for the distribution of its peptones and hydrolysates into Europe & Asia Pacific. The partnership expands Nu-Tek’s reach and continues to solidify its position as the market leader in animal-free ingredients. As a leading global distribution partner and formulator of specialty chemicals and ingredients, IMCD enables Nu-Tek to serve local customers locally while expanding the IMCD product line.

Regional Market

Peptone contains a variety of nutrients and is widely used in the production and mass production of biological drugs and antibodies. With the continuous development of the biotechnology industry, the demand for peptone is also increasing. Especially in China and India, as developing economies, the biotechnology industry is developing rapidly, which will continue to provide a driving force for the peptone market in China and India. China's biopharmaceutical industry has developed rapidly and has made considerable progress in recent years. According to CFDA regulations, the country has approved thousands of grants for the production of biological agents; of these, more than 95% are therapeutic biological agents launched in the Chinese market.

In recent years, the Indian government has implemented several preferential policies to encourage biopharmaceutical companies to discover new drugs and molecules. According to data from Invest India, India is the world's third-largest drug seller. The country has more than 3,000 pharmaceutical companies and a network of more than 10,500 manufacturing plants. As many government-sponsored medical and pharmaceutical institutions have state-of-the-art facilities, clinical trials, and research are now the main business in India, and these facilities can serve as ideal centers for conducting multi-center clinical trials. Compared with developed countries, India's research and development costs are greatly reduced, and it is possible to carry out new drug discovery research and new drug delivery system programs at a competitive price. All these factors are expected to surge the country's demand for peptone in the next few years.

By Type	Microbial Peptone
	Vegetable Peptone
	Animal Peptone
	The vegetable peptone segment contributes the largest share.
By Application	Pharmaceutical Culture Media
	Industrial Fermentation
	Microbe Research Institutions
	Crop Protection & Plant Care
	Other
	The pharmaceutical culture media segment occupies the biggest share.

For more industry information, please refer to our latest released "2023 Global Peptone Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast".